Zhongnan Medical Journal Press

Home Results

A total of 2306 result was found. Results that relate to R

Evaluation of the effects of different sterilization methods on the quality of Amomi Fructus raw powder evaluated by AHP-entropy weight TOPSIS

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):795-803.
859 times 159 times

CAO Ling SHI Guoli CUI Linlin GAO Yanhong WANG Ning LIU Yuanhui JIN Zongyuan LI Weiqun

Amomi Fructus Raw powder AHP-entropy weight TOPSIS Dry heat sterilization Moist heat sterilization Ultraviolet sterilization Irradiation sterilization
Details
Simultaneous determination of 10 impurities in ibuprofen and its preparations by UPLC method

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):804-812.
870 times 161 times

YUN Xiaofei ZHANG Yanxia QIAN Yujuan HAN Feng XIAO Honghua YAN Zeman WANG Meng

Ibuprofen Ultra-performance liquid chromatography Impurities Toxicity Quality control
Details
Retrospective study on the efficacy of insulin degludec/insulin aspart combined with dietary management in patients with type 2 diabetes mellitus

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):813-819.
847 times 159 times

XIANG Yuyang XIE Yuye LIN Zhihao

Type 2 diabetes mellitus Insulin degludec/insulin aspart Integrated diet management model Efficacy observation
Details
Establishment of drug utilization evaluation criteria for bemiparin sodium and its clinical application

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):820-827.
852 times 161 times

YE Chenli HONG Weimin HAN Yutong CAO Weiling

Bemiparin sodium Drug utilization evaluation Delphi method Off-label use Rational drug use
Details
Research progress on herbal textual research and pharmacological effects of Changium smyrnioides Wolff

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):828-838.
998 times 186 times

DOU Haoran LIU Yu YI Bowen

Changium smyrnioides Wolff Processing Efficacy Herbal textual research Pharmacological effects
Details
Research progress on food-medicine homology substances in metabolic dysfunc-tion-associated steatotic liver disease

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):839-847.
981 times 172 times

SUN Mingyu LI Ming ZHANG Hao

Food-medicine homology substances Metabolic dysfunction-associated steatotic liver disease Lipid metabolism Liver fibrosis Mechanism of action
Details
Research progress on clinical application and mechanisms of traditional Chinese medicine formulas in postpartum hypogalactia

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):848-856.
921 times 143 times

CHENG Kun FU Xianjun LI Xiuxue

Postpartum hypogalactia Traditional Chinese medicine formulas Clinical research Syndrome differentiation Mechanism of action
Details
Research progress on multidrug resistance mechanism of non-small cell lung cancer and reversal effect of active ingredients of traditional Chinese medicine

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):857-866.
807 times 148 times

ZHENG Wanrong LAI Fobao

Tumor multidrug resistance Non-small cell lung cancer Active components of traditional Chinese medicine Resistance reversal Non-coding RNA Programmed cell death
Details
Research progress on traditional Chinese medicine combined with chemotherapeutic drugs in the treatment of colorectal cancer

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):867-875.
780 times 133 times

LIU Qingrui WANG Lu CHEN Hao WANG Pei HUANG Chuyue ZHOU Bingwen DONG Yujing FAN Zhimin

Colorectal cancer Traditional Chinese medicine Enhancing efficacy and reducing toxicity Cell cycle Autophagy Apoptosis Multidrug resistance Immune microenvironment
Details
Research progress on optimized technical paths of meloxicam dosage forms

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):876-884.
710 times 137 times

YANG Jie YUAN Jing XU Shaohua LIAO Zongquan XIAO Gaofeng QU Longmei

Meloxicam Dosage form Drug delivery system Targeted preparations Sustained-release preparations Cyclooxygenase-2
Details
Interpretation of the Guiding Principles of Good AI Practice in Drug Development jointly released by FDA and EMA

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):885-894.
1589 times 558 times

ZHANG Hua LI Pengfei FU Hongjun

U.S. Food and Drug Administration European Medicines Agency Ar-tificial intelligence Drug development Guide principles Regulatory science
Details
Analysis of one case of almolertinib-induced interstitial lung disease in a lung cancer patient

Published on Frontiers in Pharmaceutical Sciences 2026,30(5):895-900.
815 times 152 times

FAN Xinxing LI Ling ZHENG Menying BAI Juan

Almonertinib Interstitial lung disease Lung cancer Adverse drug reaction
Details
Guide on Methodological Standards in Pharmacoepidemiology (2nd edition) and their series interpretation (18): analysis strategies and clinical applications of heterogeneity of treatment effect

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):601-612.
335 times 96 times

HUANG Tao SHEN Zhuoheng XU Yang

Heterogeneity of treatment effect Pharmacoepidemiology Real-world data Subgroup analysis Risk modelling Effect modelling Causal machine learning Precision medicine
Details
Interpretation of the Transparent Reporting of Observational Studies Emulating a Target Trial (TARGET) statement

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):613-624.
313 times 80 times

LIN Tengfei WU Xiaoyu HE Na LONG Yujun YANG Nan QIU Yijin ZHANG Tiantian XU Yang YANG Zhirong

Observational study Target trial emulation Reporting guideline TARGET statement Causal inference
Details
Development of a predictive model for the risk of antimicrobial drug-induced thrombocytopenia using 5 machine learning algorithms

Published on Chinese Journal of Pharmacoepidemiology 2026,35(6):625-634.
306 times 79 times

WANG Min SHEN Xiaoyan

Machine learning Antimicrobial drugs Thrombocytopenia Prediction model Risk factors Extreme gradient boosting SHapley Additive exPlanation
Details